Structure-based drug design for the discovery of new treatments for trypanosomiasis
Human African trypanosomiasis (HAT) and Chagas disease are caused by infection with the protozoan parasites Trypanosoma brucei and T. cruzi, respectively. There has historically been a lack of investment into measures to control these diseases. As a result, few drugs are available to treat HAT and C...
Main Author: | Adjogatse, E. K. |
---|---|
Published: |
University College London (University of London)
2015
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.647194 |
Similar Items
-
Immune dysfunction in African trypanosomiasis
by: Selkirk, Murray Ellis
Published: (1981) -
Chemotherapy and immunity in murine African trypanosomiasis
by: Whitelaw, D. D.
Published: (1982) -
The study of human trypanosomiasis in Malawi
by: Nyasulu, Yohane
Published: (1991) -
Some aspects of the epidemiology and chemotherapy of African trypanosomiasis
by: Chizyuka, H. G. B.
Published: (1980) -
Design and synthesis of new potential drugs for the treatment of human African trypanosomiasis
by: Baliani, Alessandro
Published: (2006)